Eosinophilia during Hantavirus infection: a cohort study

Infect Dis (Lond). 2022 Apr;54(4):277-282. doi: 10.1080/23744235.2021.2009129. Epub 2021 Nov 30.

Abstract

Background: There are emerging eosinophil-related considerations concerning viral infections. The role of eosinophils has poorly been evaluated during Hantavirus infection.

Methods: The aim of this study was to determine the prevalence of eosinophilia (defined as an eosinophil count above 500 cells/mm3) during haemorrhagic fever with renal syndrome (HFRS) in a large cohort of patients, and to identify factors associated with eosinophilia.

Results: Among 387 patients hospitalized for HFRS, 98 (25.3%) had eosinophilia. By univariate analysis, eosinophilia was significantly associated with more severe thrombocytopenia, high C-reactive protein level, white blood cell count and neutrophil count and lower nephrotoxic drug intake. As there was a collinearity between white blood cell count and C-reactive protein level, only C-reactive protein level with platelet count and nephrotoxic drug intake were entered in the multivariable analysis. Elevated C-reactive protein concentrations remained independently associated with eosinophilia.

Conclusion: Eosinophilia during HFRS affects one quarter of patients, and supports the role of eosinophils in antiviral immunity against hantavirus infection.

Keywords: Hantavirus; Nephropathia Epidemica; Puumala virus; eosinophilia; haemorrhagic fever with renal syndrome.

MeSH terms

  • C-Reactive Protein
  • Cohort Studies
  • Eosinophilia* / complications
  • Eosinophilia* / epidemiology
  • Hantavirus Infections* / complications
  • Hantavirus Infections* / epidemiology
  • Hemorrhagic Fever with Renal Syndrome*
  • Humans
  • Orthohantavirus*
  • Puumala virus*

Substances

  • C-Reactive Protein